Johnson & Johnson (JNJ) Receivables (2009 - 2026)
Johnson & Johnson's Receivables was $18.99 billion in Q3 2026, up 7.8% from $17.61 billion a year earlier but down 0.3% from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) Receivables (2009 - 2026) Analysis & Trends
At the end of FY2025, Receivables at Johnson & Johnson came in at $17.18 billion, up 15.7% from FY2024.
- Receivables shows a four-year compound annual growth rate of 6.1% (FY2021 to FY2025).
- In earlier years, Receivables was $14.84 billion in FY2024 (-0.2%), $14.87 billion in FY2023 (+5.9%), $14.04 billion in FY2022 and $13.58 billion in FY2021.
- Quarterly Receivables has moved between $14.04 billion (Q4 2022) and $19.05 billion (Q2 2026) over five years.
- Compared with a year earlier, Receivables has increased for seven straight quarters, with growth averaging 8.7% over the last eight quarters.
- The best year-over-year quarter for Receivables over five years was Q4 2025 (growth of 15.7%); the worst was Q1 2024 (a decline of 8.6%).
- Per Business Quant data, JNJ's Receivables in the three quarters before Q3 2026 was $19.05 billion (Q2 2026), $17.72 billion (Q1 2026) and $17.18 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 14.33 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn | 2.31 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 18.99 Bn |
| Jun 28, 2026 | 19.05 Bn |
| Mar 29, 2026 | 17.72 Bn |
| Dec 28, 2025 | 17.18 Bn |
| Sep 28, 2025 | 17.61 Bn |
| Jun 29, 2025 | 17.85 Bn |
| Mar 30, 2025 | 16.02 Bn |
| Dec 29, 2024 | 14.84 Bn |
| Sep 29, 2024 | 16.17 Bn |
| Jun 30, 2024 | 15.79 Bn |
| Mar 31, 2024 | 14.95 Bn |
| Dec 31, 2023 | 14.87 Bn |
| Oct 1, 2023 | 14.80 Bn |
| Jul 2, 2023 | 16.78 Bn |
| Apr 2, 2023 | 16.35 Bn |
| Jan 1, 2023 | 14.04 Bn |
| Oct 2, 2022 | 15.89 Bn |
| Jul 3, 2022 | 16.14 Bn |
| Apr 3, 2022 | 15.59 Bn |
| Jan 2, 2022 | 15.28 Bn |
API Access
Johnson & Johnson Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();